Acura Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Acura Pharmaceuticals with three other
companies in this sector in the United States:
sales of $379,026.00
Oasmia Pharmaceutical AB
of which 75%
was Royalty revenues).
Sales fell dramatically in 2018:
During the year ended December of 2018, sales at
Acura Pharmaceuticals were $410,000.00 .
decrease of 86.2%
versus 2017, when the company's sales were $2.97 million.